Raynovent Announces Acceptance of IND Application of a Category 1 Drug, ZSP0678 for NASH Indication.

Previous:Raynovent Announces Completion of Phase 1 Clinical Trial of Category 1 Drug ZSP1273.

Next:Raynovent Announces Approval of Category 1 Drug ZSP0678 for Clinical Trials of NASH Indication